Home / Resources / Webinar / A New Tool to Gain Market Access Intelligence in Minutes

A New Tool to Gain Market Access Intelligence in Minutes

Live webinar

Do you need to find out in what countries a certain drug is approved and reimbursed? Do you need to routinely follow what is happening regarding the market access landscape for small molecule and biologic drugs in your therapeutic area? And are you spending too much time searching for trustworthy information needed to inform your pricing and reimbursement strategy for payers?

Certara’s Market Access Radar (MAR) database and online repository was designed to be your go-to resource providing you in minutes with the most critical information relevant to market access.  Expert-curated, then hosted in MAR, our consultants gather the latest reimbursement recommendations, information on financing from public funds announced by Ministries of Health (MOH) and Health Technology Assessment (HTA) agencies, and changes in legal provisions regulating the financing of health technologies from public funds and much more.

Join the Certara Evidence & Access team for a presentation on how MAR is being used to help our clients succeed with their commercialization strategy. We’ll also provide a product demonstration of its core features followed by a Q&A session


Thank you for Registering!

Roman Casciano
Roman Casciano
SVP Evidence & Access
Roman Casciano is Senior Vice President within Certara's Evidence and Access Group. As an applied health economist and market access strategist, Roman has personally led hundreds of engagements in the international market access, HEOR and real world evidence context related to product value demonstration and has deep experience in both formal and informal exchanges with payers and HTA bodies.
Elvira Muller
Elvira Müller, PhD
VP HTA and Evidence Development
Elvira is an expert in HTA engagements with substantial experience in health technology assessment, reimbursement strategy and early dialogues, both national and multi-HTA via the EUnetHTA collaboration.
Pascaline Faivre
Senior Director Market Access
Pascaline Faivre (PharmD, Msc)  is a Senior Director Market Access at Certara and brings 13 years of experience in Market Access and Health economics at pharmaceutical industries and consultancy groups. Pascaline has successful track record of reimbursement submissions in EU countries, product launches, and extensive knowledge of EU market Access challenges and payers requirements for drugs, medical devices and vaccines.
Maximilian Vargas
Maximilian Vargas
Sr. Director, US Access Strategy
Maximilian Vargas, PhD MBA, is a Senior Director, US Access Strategy and Account Management within Certara’s Evidence and Access Group since 2012.  He brings both scientific training and experience in healthcare product development that are important for evidence-based value and access strategies for pipeline and marketed products.
Back to top